Enzalutamide is an androgen receptor (AR) inhibitor that works by directly binding to AR on its ligand-binding domain and blocking AR activation and signaling, which is critical for the growth and survival of prostate cancer cells. This evidence concerns the gene AR and Familial prostate cancer.